EUVIMEDEUVIMED entdecken
Querschnittstudie

Usefulness of Prostaglandin E-Major Urinary Metabolite in Monitoring Crohn’s Disease Activity: A Prospective Cross-Sectional Study

Natsuki Ishida, Satoshi Tamura, Tomohiro Takebe, Kenichi Takahashi, Yusuke Asai, Tomoharu Matsuura, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Takanori Yamada, Satoshi Osawa, Ken Sugimoto iD

Inflammatory Bowel Diseases · 2025

DOI: 10.1093/ibd/izaf025 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Natsuki Ishida und 11 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan. Hauptthemen laut MEDLINE: Crohn Disease, Biomarkers. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The goal of treatment for Crohn’s disease (CD) is to achieve mucosal or transmural healing, and biomarker measurements are useful in monitoring disease activity and guiding treatment. This study aimed to investigate the utility of a new urinary biomarker, prostaglandin E-major urinary metabolite (PGE-MUM), in assessing CD activity.

Methods

The study involved 87 patients with CD who underwent endoscopic examination and measurements of 4 biomarkers: Prostaglandin E-major urinary metabolite, fecal calprotectin (FC), leucine-rich α2 glycoprotein (LRG), and C-reactive protein (CRP). Endoscopic activity was assessed by the Simple Endoscopic Score for Crohn’s Disease (SES-CD). Correlations between the CD activity index (CDAI) and SES-CD with the 4 biomarkers were analyzed, and receiver-operating characteristic (ROC) analyses were performed to predict SES-CD ≧ 3.

Results

All 4 biomarkers showed significant correlations with both CDAI and SES-CD. The cutoff (area under the curve [AUC]) values for predicting SES-CD ≥ 3 were as follows: PGE-MUM, 25.2 µg/g Cr (0.800); FC, 257 mg/kg (0.816); LRG, 11.8 µg/mL (0.748); and CRP, 0.22 mg/dL (0.656). Subgroup analysis revealed significant correlations between PGE-MUM and SES-CD in both the L1 (small intestine only) and L2 + L3 (including large intestine) groups, with correlation coefficients of 0.654 and 0.586, respectively. In the L1 group, ROC analysis revealed that, among the 4 biomarkers, PGE-MUM had the highest AUC for predicting SES-CD ≥ 3, with a cutoff (AUC) of 33.1 µg/g Cr (0.861).

Conclusions

PGE-MUM is a biomarker that can reflect endoscopic activity in patients with CD and may be particularly useful in small intestinal lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseBiomarkersHumansFemaleMaleProspective StudiesCross-Sectional StudiesAdultLeukocyte L1 Antigen ComplexMiddle AgedC-Reactive ProteinROC CurveFecesYoung AdultSeverity of Illness IndexFollow-Up StudiesPrognosisGlycoproteins

Stichwörter der Autor:innen

Crohn’s diseasefecal calprotectinprostaglandin E-major urinary metabolitesimple endoscopic score for Crohn’s disease

Substanzen

BiomarkersLeukocyte L1 Antigen ComplexC-Reactive ProteinLRG1 protein, humanGlycoproteins

Autor:innen und Institutionen

  • First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
  • Department of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
  • Department of Endoscopic and Photodynamic Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.

ORCID-Profile: Ken Sugimoto

Zitieren

APA

Ishida, N., Tamura, S., Takebe, T., Takahashi, K., Asai, Y., Matsuura, T., Yamade, M., Iwaizumi, M., Hamaya, Y., Yamada, T., Osawa, S., & Sugimoto, K. (2025). Usefulness of Prostaglandin E-Major Urinary Metabolite in Monitoring Crohn’s Disease Activity: A Prospective Cross-Sectional Study. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf025

Vancouver

Ishida N, Tamura S, Takebe T, Takahashi K, Asai Y, Matsuura T, et al. Usefulness of Prostaglandin E-Major Urinary Metabolite in Monitoring Crohn’s Disease Activity: A Prospective Cross-Sectional Study. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izaf025

BibTeX
@article{Ishida2025,
  author = {Ishida, Natsuki and Tamura, Satoshi and Takebe, Tomohiro and Takahashi, Kenichi and Asai, Yusuke and Matsuura, Tomoharu and Yamade, Mihoko and Iwaizumi, Moriya and Hamaya, Yasushi and Yamada, Takanori and Osawa, Satoshi and Sugimoto, Ken},
  title = {Usefulness of Prostaglandin E-Major Urinary Metabolite in Monitoring Crohn’s Disease Activity: A Prospective Cross-Sectional Study},
  journal = {Inflammatory Bowel Diseases},
  year = {2025},
  doi = {10.1093/ibd/izaf025}
}
Kostenlos starten →